Search - tctmd.com

Displaying 21 - 40 of 1123

Sort: Relevancy | Date

Presentation TCT 2025

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Presenter: Lei Song

October 27, 2025

Presentation TCT 2025

TCT 1895: Optical Coherence Tomography (OCT) Findings, Management, and Follow-Up of a Dislodged Magnesium-Based Bioresorbable Scaffold

Presenter: Abigail CC Chng

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Presentation TCT 2025

TCT 232: Comparison of 2 novel Limus delivery devices at 28 & 90 days: CASPER MRS vs. SELUTION DCB

Presenter: Antonio Colombo

October 26, 2025

Presentation TCT 2025

TCT 234: Acute and Late Relocation of Minimal Lumen Area after Implantation of a Magnesium-based Bioresorbable Scaffold

Presenter: Jens Trøan

October 26, 2025

Presentation TCT 2025

TCT 231: A Novel Magnesium Fully Resorbable Scaffold (MRS) Eluting Biolimus A9 at 28 Days in a Rabbit Iliac Model

Presenter: Antonio Colombo

October 26, 2025

Presentation TCT 2025

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

Presenter: Sultana Jahan

October 26, 2025

Presentation TCT 2025

TCT 233: FANTOM II Study: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – Pooled Analysis From 3 Study Cohorts

Presenter: Matthias Lutz

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Presentation TCT 2025

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

Presenter: S. Jay Mathews

October 26, 2025

Presentation TCT 2025

A Novel Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Technology Description and Clinical Results

Presenter: Lei Song

October 26, 2025

Presentation TCT 2025

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Presenter: Scott Harding

October 26, 2025

Presentation TCT 2025

TCT 202: Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: First Patient-Level Pooled Analysis Comprising Randomized IRONMAN-II Trial and Prospective IRONMAN-III Registry

Presenter: Lei Song

October 26, 2025

Presentation TCT 2025

Dissolving Barriers: Bioresorbable Scaffolds in Action

Presenter: Catherine Popik

October 25, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Advertisement

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

TCT 1895: Optical Coherence Tomography (OCT) Findings, Management, and Follow-Up of a Dislodged Magnesium-Based Bioresorbable Scaffold

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

TCT 232: Comparison of 2 novel Limus delivery devices at 28 & 90 days: CASPER MRS vs. SELUTION DCB

TCT 234: Acute and Late Relocation of Minimal Lumen Area after Implantation of a Magnesium-based Bioresorbable Scaffold

TCT 231: A Novel Magnesium Fully Resorbable Scaffold (MRS) Eluting Biolimus A9 at 28 Days in a Rabbit Iliac Model

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

TCT 233: FANTOM II Study: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – Pooled Analysis From 3 Study Cohorts

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

A Novel Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Technology Description and Clinical Results

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

TCT 202: Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: First Patient-Level Pooled Analysis Comprising Randomized IRONMAN-II Trial and Prospective IRONMAN-III Registry

Dissolving Barriers: Bioresorbable Scaffolds in Action

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content